Study for Verification of Efficacy and Safety for Perampanel Monotherapy in Untreated Participants With Partial Onset Seizures (Including Secondarily Generalized Seizures (FREEDOM Study)

NCT03201900 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
91
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Eisai Co., Ltd.